Friday, 27 March 2026

The Lilly executive upending the drug giant’s cancer pipeline

March 27, 2026
avatar-angus-chen
Cancer Reporter

About three years ago, Mayo Clinic started a pilot program called Cancer CARE Beyond Walls to let some patients get chemotherapy infusions at home. Last week, investigators from Mayo Clinic published an analysis of that program, showing that it had certain benefits for patients. In the program, a "command center" of physicians and advanced practice clinicians (like NPs or PAs) at Mayo Clinic would coordinate remote care and monitor patients. A staff of mobile clinicians would deliver the care remotely.

Programs like this might be important as cancer incidence rises, and there are more cancer survivors who may need ongoing care and monitoring, according to the authors. One thing that's cool to me about programs like this is the idea that you could be able to bring cancer therapy to more places that don't have easy access to infusion clinics, so it's interesting to see that the authors reported a successful home infusion program.

That being said, the program only had an operating distance of 35 miles from the medical center, but the authors note that they believe scaling out to rural areas is possible. Certainly, physical infrastructure for cancer care isn't the only limitation to rural care, though, as those areas might lack an adequate cancer workforce.


Jacob Van Naarden is president of Lilly Oncology and head of business development for the drug giant.
James Salzano/Eli Lilly

STAT+ | How an outsider crept into Eli Lilly's top ranks — and plans to drive its business forward 

Lilly acquired both drug rights and top talent in the $8 billion deal. Here's an inside look at how Loxo's Jacob Van Naarden rose to power inside Eli Lilly.

By Matthew Herper


STAT+ | FDA slams Soon-Shiong and ImmunityBio for making 'false and misleading' claims about a drug

The FDA sent a warning letter in which it maintained 'material facts' and risks associated with the cancer drug were omitted.

By Ed Silverman


Decades after Vietnam War, research links Agent Orange exposure to MDS blood cancer

Q&A with Mikkael Sekeres on his 8-year quest to link myelodysplastic syndromes to herbicide used in Vietnam: "Feel like I'm doing something for my country."

By Angus Chen



Andres Vidal-Gadea, a professor of molecular neuroethology, at his lab at Illinois State University.
Taylor Glascock for STAT

NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists

National survey of NIH grant recipients shows a quarter were significantly affected by a ban on sharing their funding with partners overseas.

By Megan Molteni, Anil Oza, and Jonathan Wosen


More around STAT

In other news

  • Allogene's off-the-shelf CAR-T is nearing an early but pivotal study readout, STAT
  • Trump EPA relied on industry science to weaken formaldehyde cancer rules, documents show, The Guardian

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments:

Post a Comment